Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.01 USD | -0.99% | -4.07% | -83.86% |
May. 14 | Wolfe Research Downgrades RAPT Therapeutics to Peer Perform From Outperform | MT |
May. 10 | Guggenheim Downgrades RAPT Therapeutics to Neutral From Buy | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-83.86% | 140M | |
+11.91% | 118B | |
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.82% | 21.96B | |
-10.12% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B |
- Stock Market
- Equities
- RAPT Stock
- News RAPT Therapeutics, Inc.
- JPMorgan Adjusts Price Target on RAPT Therapeutics to $42 From $48, Maintains Overweight Rating